Faceki Review 2026: Pricing, Features & Alternatives

PrimeBiometry Assessment

Faceki is a pre-seed stage eKYC vendor founded in 2020, positioning itself around speed: specifically sub-30-second identity verification from any location. With a usage-based pricing model and a small team of 11-50 employees, it targets the cost-sensitive end of the KYC market. There are zero published reviews across major review platforms, meaning all performance claims rest entirely on vendor-provided data. Buyers should treat this as an early-adopter engagement rather than a validated enterprise procurement.

Best For

Early-stage fintechs and KYC-obligated platforms with under 5,000 verifications/month that need a usage-based model without per-seat minimums, and are comfortable being an early customer with limited third-party validation available.

Avoid If

Regulated financial institutions, insurance carriers, or any organization requiring documented compliance certifications, published SLAs, or independently verified accuracy metrics before deployment.

Compliance Coverage

Standard	Status
GDPR	✗
CCPA	✗
SOC 2	✗
ISO 27001	✗
HIPAA	✗

Integration Complexity

Medium – Faceki’s published materials reference API access for eKYC flows, but no public SDK documentation or developer portal was found during assessment. Expect integration to require direct vendor support contact for onboarding details.

Pricing Analysis

Faceki’s pricing model is usage-based per month, which is favorable for low-volume or variable-volume use cases: you pay for what you verify rather than a flat platform fee. For startups running fewer than 1,000 verifications/month, this model avoids the overhead of fixed-tier pricing common among larger vendors.

However, no published pricing rates or volume brackets are available. Without a disclosed per-verification rate, it is impossible to model costs ahead of procurement. Request a formal per-verification rate card and minimum monthly commitment terms before entering any agreement. Given the pre-seed funding stage ($8.5B total funding figure in the data appears anomalous for a pre-seed company: verify independently), long-term vendor viability is a legitimate concern to raise during due diligence.